Entecavir Dispersible Tablets 0.5?mg (He’en) – Low price Wholesale

Entecavir Dispersible Tablets 0.5?mg (He’en) – Low price Wholesale

$1.00

He’en’s Entecavir Dispersible Tablets feature 0.5?mg entecavir per tablet, packaged as 4 blisters of 7 tablets each (total 28). Manufactured by Hainan Zhonghe Pharmaceutical Co., Ltd., and approved under NMPA H20100064, this format dissolves easily in water, making it ideal for pediatric, in vitro, or formulation research. ?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Entecavir is a potent guanosine nucleoside analogue that inhibits hepatitis B virus (HBV) polymerase at multiple stages—blocking reverse transcription, priming, and DNA synthesis. The dispersible tablet ensures rapid administration, enabling flexible dosing in animal models and dissolution-based assays.


Entecavir Dispersible Tablets Product Specifications

ParameterDetails
Product NameEntecavir Dispersible Tablets (He’en)
Generic NameEntecavir
CAS Number142217?69?4
Molecular FormulaC??H??N?O?
Molecular Weight~277.28?g/mol
Dosage FormDispersible tablet
Strength0.5?mg per tablet
Pack Size28 tablets (7 tablets × 4 blisters)
Approval No.H20100064
Drug Code86905842000471
ManufacturerHainan Zhonghe Pharmaceutical Co., Ltd.
Barcode6927516988940
Storage ConditionsStore sealed below 30?°C, protect from moisture
Intended UseLaboratory research—HBV inhibition, pharmacokinetics, pediatric models

Entecavir Dispersible Tablets Mechanism of Action

Entecavir competes with deoxyguanosine triphosphate to inhibit HBV polymerase, effectively halting virus replication by preventing priming, reverse transcription, and viral DNA synthesis. Its pharmacokinetic profile supports once-daily dosing, aided by a long half-life (128–149 hours).


Research Application Areas

  • HBV replication assays: Inhibition of viral polymerase function

  • Resistance mutation studies: Evaluating viral evasion mechanisms

  • Pharmacokinetics & bioequivalence: Including pediatric formulation comparisons

  • Pediatric and formulation research: Due to its dispersible nature

  • Combination therapy modeling: Integrase with other antivirals


Safety & Handling

  • Handling: Use in vitro or oral dosing in animal studies; employ standard PPE.

  • Storage: Keep sealed below 30?°C, in a dry environment.

  • Precautions: Not for clinical human use; monitor viral markers in prolonged studies.

  • Contraindications: Not intended for HBV-HIV co-infection without antiretroviral background.


Core Keywords

entecavir dispersible tablets, CAS 142217-69-4, H20100064 entecavir, HBV research tablet, pediatric antiviral tablet, lab-grade entecavir, wholesale antiviral tablets


Research Use Disclaimer

For laboratory and preclinical research only. Not approved for clinical, therapeutic, diagnostic, or veterinary applications. Misuse may pose legal or health risks. Use under institutional protocols.

Additional information

Weight1 kg
Dimensions26 × 21 × 26 cm

Reviews

There are no reviews yet.

Be the first to review “Entecavir Dispersible Tablets 0.5?mg (He’en) – Low price Wholesale”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare